Observe Medical Asa · OSL:OBSRV
Observe Medical Asa — Investor Presentation (November 2023)
16 slides from Observe Medical Asa's investor presentation, November 2023
Slide 1: Observe Medical Investor Presentation November 2023
“eovserve medical Observe Medical Investor Presentation November 2023
Slide 2: Copyright and disclaimer
Copyright and disclaimer Copyright Copyright of all published material including photographs, drawings and images in this document remains vested in Observe Medical and third-party contributors as appropriate. Accordingly, neither the whole nor any part of this document shall be reproduced in any fo
Slide 3: Transaction summary
Transaction summary Subscription Rights per old share: 3.9546 Subscription Price: NOK 0.26 per share Gross Proceeds: Approx. NOK 18-55 million Start of Application Period: 28 November 2023 End of Application Period: 12 December 2023 Trading in Subscription Rights starts: 28 November 2023 Trading in
Slide 4: Today's presenters
INTRODUCTION Today’s presenters Terje Bakken Rune Nystad Per Arne Nygård Jørgen Mann Nilsen Executive Chairman of the Board Chief Executive Officer Chief Financial Officer Chief Commercial Officer Terje is a partner in the 20+ years of experience 20+ years of experience 20+ years experience from Nor
Slide 5: Observe Medical: Nordic medtech company with global reach
INTRODUCTION Observe Medical Nordic medtech company with global reach Commercializing proprietary innovative medtech products on a global market. Extensive international distributor and partner network. Solid platform for further organic growth and through targeted M&A. Strong medtec platform Urine
Slide 6: 2023: A truly transformative year
2023: A truly transformative year UnoMeter™ Abdo-Pressure Convatec transaction Vingmed partnership First shipment of UnoMeter™ Abdo- Signing agreement with Convatec Signing of LOI for a forthcoming Pressure products to customers to acquire the trademarks and other exclusive Nordic distribution intel
Slide 7: Initial UnoMeter orders of NOK 14m received
BUSINESS UPDATE Initial UnoMeter™ orders of NOK 14m received, representing repetitive expected sales of NOK ~108m per year1 1 Step 1: Completed (as of Nov’23) Received orders from Italy, Spain, UK, Portugal, UAE, Vietnam, Austria, The Netherlands, Sweden, Poland, Romania, NOK ~200m NOK ~200m1 Bulgar
Slide 8: Building the foundation to become the global leading urine measurement provider
BUSINESS UPDATE Building the foundation to become the global leading urine measurement provider Executing according to plan: ✓ Signing of LOI with Convatec in Q3 2022 ✓ Building relationships with key distribution partners ✓ Signing of Convatec transaction and license agreement ✓ Full scale global p
Slide 9: Continuing the commercial groundwork for the UnoMeter portfolio will accelerate Sippi
BUSINESS UPDATE Continuing the commercial groundwork for the UnoMeter™ portfolio will accelerate the market introduction of Sippi Recapture the market through UnoMeter™ Upsell Sippi to existing clients at higher price points and better margins UnoMeter™ 500 Abdo-Pressure UnoMeter™ Safeti Plus and Pr
Slide 10: Perfect Match: global dialysis market potential for Biim
BUSINESS UPDATE The global dialysis market opens for a huge potential for Biim The product The market potential within dialysis is huge ✓ Ultrasound made-simple ✓ An intuitive and low complexity device There are In the global market there ~7,500 dialysis clinics are ~40,000 dialysis ✓ Pocketable and
Slide 11: Positive outlook for further Biim roll-out in Fresenius clinics
BUSINESS UPDATE Positive outlook for further Biim roll-out in Fresenius clinics Fresenius Partnership opens extensive growth Project status opportunities ➢ Fresenius Medical Care is the world’s largest ✓ 265 Probes delivered in 2021-2022 provider of dialysis, dialysis product and other services ✓ 10
Slide 12: Full scale global production to secure high volume delivery
BUSINESS UPDATE Full scale global production to secure high volume delivery of quality products with attractive margins Jan - April May June - July Aug-Sept Okt - Nov Dec Global production Production CE certification Start of pilot Start of high partner selection partner Unometer 500 production volu
Slide 13: Business plan to reach positive free cash from Q3 2024
KEY FINANCIALS Business plan to reach positive free cash from Q3 2024 Illustrative free cash-flow forecast1,2 Illustrative sources & uses (NOKm)2 6 Uses: Cash for Unometer 14.0 4 Cash for Biim 8.0 Cash for Sippi 5.5 2 Second installment Convatec ATA 5.5 Expected conversion of interest-bearing loans
Slide 14: Unchanged run-rate revenue expectations of NOK 220m
KEY FINANCIALS Unchanged run-rate revenue expectations of NOK 220m Estimated run-rate revenue of NOK 220m end 20241,2,3 Estimated EBITDA based on a NOK 220m run-rate2 (NOK in millions) (NOK in millions) Nordic Sippi Biim Unometer Platform Gross profit OPEX EBITDA Distribution run-rate Estimated gros
Slide 15: Our view of the future as we enter 2024
BUSINESS UPDATE Our view of the future as we enter 2024 600+ distributors/customers 50+ countries NOK 220 mill run rate Global leading provider of urine measurement products Entering 2022 Preferred provider of Biim presence 2022/2023 ultrasound probes to UnoMeter™ presence 2023 Fresenius globally Re
Slide 16: oKeobserve
oKeobserve medical
Observe Medical — Investor Presentation (November 2023) on 6ix